$DOCS

Director at Doximity (NYSE: DOCS) lines up 2,000-share sale

Doximity (DOCS) director Kira Wampler plans to sell 2,000 shares, valued at $52,660, under Rule 144 after exercising stock options. This follows a similar sale of 2,000 shares in August 2026. Doximity has 127.3 million shares outstanding.

Original reporting
Published Sep 1, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DOCS
Neutral
high confidence
Mentioned
$DOCS
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DOCSNeutralLow
01

Why it matters

The filing provides the first public notice of the insider's intent to sell a small block of stock, adding slight supply to the market.

02

Market read

A routine insider sale with limited market impact; primarily of interest to short‑term traders monitoring supply.

03

What to watch

Potential future dilution from the director's option exercises could be a longer‑term consideration.

Relevance 4/10Novelty 5/10Timing: sale planned for 09/01/2026

Background

A Form 144 filing by Doximity director Kira Wampler announces a planned sale of 2,000 shares.

Company-level read

Ticker impact

$DOCSNeutralHigh confidence
Context

Director Kira Wampler filed a Rule 144 notice to sell 2,000 Doximity shares worth $52,660.

Expected impact

Limited downward pressure; unlikely to move price materially.

Evidence & confidence

The transaction size is tiny relative to float and market cap, and the director is not a major shareholder.

Market effects

Minimal effect on the healthcare staffing and professional networking sector.

US equity market only.

Low

Counterpoint

The sale size is negligible and may not indicate any negative sentiment from insiders.

Key entities

  • Doximity, Inc.

    US‑listed professional networking platform for healthcare providers.

  • Kira Wampler

    Director of Doximity filing a Rule 144 notice.

Related articles

MedAI 8/10

Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance

Doximity's former chief revenue officer, Paul Jorgensen, was ordered to pay $490,000 to the SEC for insider trading. He sold shares based on nonpublic information ahead of negative earnings announcements, avoiding losses and making $2.2 million in profits. Jorgensen was also sentenced to 26 months in prison and ordered to forfeit $2.5 million in a parallel criminal case.

$DOCSMed

Doximity stock falls as Freedom Capital cuts to hold

Doximity Inc (DOCS) shares dropped 5.6% after Freedom Capital downgraded it to Hold, raising its price target to $27. The company beat Q1 estimates, increased full-year revenue guidance, but lowered EBITDA outlook due to AI investment. Freedom Capital noted strong AI search traction but margin concerns and core business softening.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.